insurance covering glp 1 Insurer strategies to control costs associated with weight loss drugs The GLP-1 Knowledge Gap |

Description

The appetite suppression that defines GLP-1 therapy means the drive to eat is something we cant count on

Although this is less common when Semaglutide GLP-1 is used alone as a monotherapy, the associated risk escalates in conjunction with other diabetic drugs, particularly insulin and sulfonylureas

Dillon EL, Sheffield-Moore M, Paddon-Jones D, Gilkison C, Sanford AP, Casperson SL, et al

Maintaining a healthy body weight is both a consequence and a contributor to optimal metabolic health

GLP-1 Maintenance: Ozempic & Mounjaro Micro-Dosing After Weight Loss Over the last few years, medications like Ozempic and Mounjaro have transformed how people approach weight loss